Doctor profile · Federal record
Dr. QUENTIN CHAMBERS, RN, FMHNP
Psychiatric/Mental Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · DES MOINES, IA
- NPI 1750794319
- Accepts Medicare
- 13 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
699 WALNUT ST STE 400
DES MOINES, IA 503093962
(888) 534-8913
fax (888) 534-9208 - Mailing address
-
114 KLAMBERG LN
ELLISVILLE, MO 630214739
Credentials & registration
- NPI registered
- June 2014 — 12 yrs on file
- Profile last updated
- December 22, 2025
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LP0808X — NUCC code
- State license (1)
- Missouri #2014017973
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750794319. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
263
Distinct HCPCS
3
Medicare allowed
$20,034
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 114 | 28 | $105 | |
90833 |
Psychotherapy with evaluation and management visit, 30 minutes | 80 | 22 | $57 | |
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 69 | 31 | $50 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 74. This provider delivers 3.6× the peer median.Open Payments
Industry payments received
All-time total
$1,639
Transactions
54
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $415.01 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $254.09 | |
| ABBVIE INC. | 4 | $189.09 | |
| Alkermes, Inc. | 5 | $152.18 | |
| Janssen Pharmaceuticals, Inc | 5 | $125.08 | |
| Vanda Pharmaceuticals Inc. | 1 | $124.97 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $112.47 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98.46 | |
| Otsuka America Pharmaceutical, Inc. | 4 | $91.28 | |
| Neurocrine Biosciences, Inc. | 3 | $59.07 | |
| Indivior Inc. | 1 | $17.76 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,105
Patients
72
Total drug cost
$138,035
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trazodone Hcl | Generic | 119 | 12 | $1,485 |
| Lamotrigine | Generic | 113 | 11 | $1,073 |
| Quetiapine Fumarate | Generic | 104 | 0 | $2,921 |
| Buspirone Hcl | Generic | 98 | 13 | $2,239 |
| Trintellix (Vortioxetine Hydrobromide) | Brand | 84 | 11 | $41,049 |
| Clonazepam | Generic | 79 | 13 | $1,222 |
| Aripiprazole | Generic | 75 | 12 | $5,429 |
| Alprazolam | Generic | 67 | 0 | $716 |
| Gabapentin | Generic | 64 | 0 | $1,300 |
| Vraylar (Cariprazine Hcl) | Brand | 57 | 0 | $76,678 |